Copyright Reports & Markets. All rights reserved.

Global Platelet Rich Plasma (PRP) Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Platelet Rich Plasma (PRP) Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Platelet Rich Plasma (PRP) Market Size Growth Rate by Type
    • 1.4.2 P-PRP
    • 1.4.3 L-PRP
    • 1.2.4 L-PRF
  • 1.3 Market by Application
    • 1.3.1 Global Platelet Rich Plasma (PRP) Market Size Growth Rate by Application
    • 1.3.2 Orthopedic Surgery
    • 1.3.3 Cosmetic Surgery
    • 1.3.4 General Surgery
    • 1.3.5 Other Surgeries
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Platelet Rich Plasma (PRP) Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Platelet Rich Plasma (PRP) Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Platelet Rich Plasma (PRP) Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Platelet Rich Plasma (PRP) Regions by Sales
    • 2.4.1 Global Top Platelet Rich Plasma (PRP) Regions by Sales (2016-2021)
    • 2.4.2 Global Top Platelet Rich Plasma (PRP) Regions by Sales (2022-2027)
  • 2.5 Global Top Platelet Rich Plasma (PRP) Regions by Revenue
    • 2.5.1 Global Top Platelet Rich Plasma (PRP) Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Platelet Rich Plasma (PRP) Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Platelet Rich Plasma (PRP) Sales by Manufacturers
    • 3.1.1 Global Top Platelet Rich Plasma (PRP) Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Platelet Rich Plasma (PRP) Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Platelet Rich Plasma (PRP) Sales in 2020
  • 3.2 Global Platelet Rich Plasma (PRP) Revenue by Manufacturers
    • 3.2.1 Global Top Platelet Rich Plasma (PRP) Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Platelet Rich Plasma (PRP) Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Platelet Rich Plasma (PRP) Revenue in 2020
  • 3.3 Global Platelet Rich Plasma (PRP) Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Platelet Rich Plasma (PRP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Platelet Rich Plasma (PRP) Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Platelet Rich Plasma (PRP) Sales by Type
    • 4.1.1 Global Platelet Rich Plasma (PRP) Historical Sales by Type (2016-2021)
    • 4.1.2 Global Platelet Rich Plasma (PRP) Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Platelet Rich Plasma (PRP) Sales Market Share by Type (2016-2027)
  • 4.2 Global Platelet Rich Plasma (PRP) Revenue by Type
    • 4.2.1 Global Platelet Rich Plasma (PRP) Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Platelet Rich Plasma (PRP) Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Platelet Rich Plasma (PRP) Revenue Market Share by Type (2016-2027)
  • 4.3 Global Platelet Rich Plasma (PRP) Price by Type
    • 4.3.1 Global Platelet Rich Plasma (PRP) Price by Type (2016-2021)
    • 4.3.2 Global Platelet Rich Plasma (PRP) Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Platelet Rich Plasma (PRP) Sales by Application
    • 5.1.1 Global Platelet Rich Plasma (PRP) Historical Sales by Application (2016-2021)
    • 5.1.2 Global Platelet Rich Plasma (PRP) Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Platelet Rich Plasma (PRP) Sales Market Share by Application (2016-2027)
  • 5.2 Global Platelet Rich Plasma (PRP) Revenue by Application
    • 5.2.1 Global Platelet Rich Plasma (PRP) Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Platelet Rich Plasma (PRP) Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Platelet Rich Plasma (PRP) Revenue Market Share by Application (2016-2027)
  • 5.3 Global Platelet Rich Plasma (PRP) Price by Application
    • 5.3.1 Global Platelet Rich Plasma (PRP) Price by Application (2016-2021)
    • 5.3.2 Global Platelet Rich Plasma (PRP) Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Platelet Rich Plasma (PRP) Market Size by Type
    • 6.1.1 North America Platelet Rich Plasma (PRP) Sales by Type (2016-2027)
    • 6.1.2 North America Platelet Rich Plasma (PRP) Revenue by Type (2016-2027)
  • 6.2 North America Platelet Rich Plasma (PRP) Market Size by Application
    • 6.2.1 North America Platelet Rich Plasma (PRP) Sales by Application (2016-2027)
    • 6.2.2 North America Platelet Rich Plasma (PRP) Revenue by Application (2016-2027)
  • 6.3 North America Platelet Rich Plasma (PRP) Market Size by Country
    • 6.3.1 North America Platelet Rich Plasma (PRP) Sales by Country (2016-2027)
    • 6.3.2 North America Platelet Rich Plasma (PRP) Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Platelet Rich Plasma (PRP) Market Size by Type
    • 7.1.1 Europe Platelet Rich Plasma (PRP) Sales by Type (2017-2027)
    • 7.1.2 Europe Platelet Rich Plasma (PRP) Revenue by Type (2017-2027)
  • 7.2 Europe Platelet Rich Plasma (PRP) Market Size by Application
    • 7.2.1 Europe Platelet Rich Plasma (PRP) Sales by Application (2017-2027)
    • 7.2.2 Europe Platelet Rich Plasma (PRP) Revenue by Application (2017-2027)
  • 7.3 Europe Platelet Rich Plasma (PRP) Market Size by Country
    • 7.3.1 Europe Platelet Rich Plasma (PRP) Sales by Country (2017-2027)
    • 7.3.2 Europe Platelet Rich Plasma (PRP) Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Platelet Rich Plasma (PRP) Market Size by Type
    • 8.1.1 Asia Pacific Platelet Rich Plasma (PRP) Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Platelet Rich Plasma (PRP) Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Platelet Rich Plasma (PRP) Market Size by Application
    • 8.2.1 Asia Pacific Platelet Rich Plasma (PRP) Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Platelet Rich Plasma (PRP) Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Platelet Rich Plasma (PRP) Market Size by Region
    • 8.3.1 Asia Pacific Platelet Rich Plasma (PRP) Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Platelet Rich Plasma (PRP) Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Platelet Rich Plasma (PRP) Market Size by Type
    • 9.1.1 Latin America Platelet Rich Plasma (PRP) Sales by Type (2019-2027)
    • 9.1.2 Latin America Platelet Rich Plasma (PRP) Revenue by Type (2019-2027)
  • 9.2 Latin America Platelet Rich Plasma (PRP) Market Size by Application
    • 9.2.1 Latin America Platelet Rich Plasma (PRP) Sales by Application (2019-2027)
    • 9.2.2 Latin America Platelet Rich Plasma (PRP) Revenue by Application (2019-2027)
  • 9.3 Latin America Platelet Rich Plasma (PRP) Market Size by Country
    • 9.3.1 Latin America Platelet Rich Plasma (PRP) Sales by Country (2019-2027)
    • 9.3.2 Latin America Platelet Rich Plasma (PRP) Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Platelet Rich Plasma (PRP) Market Size by Type
    • 6.1.1 Middle East and Africa Platelet Rich Plasma (PRP) Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Platelet Rich Plasma (PRP) Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Platelet Rich Plasma (PRP) Market Size by Application
    • 6.2.1 Middle East and Africa Platelet Rich Plasma (PRP) Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Platelet Rich Plasma (PRP) Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Platelet Rich Plasma (PRP) Market Size by Country
    • 6.3.1 Middle East and Africa Platelet Rich Plasma (PRP) Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Platelet Rich Plasma (PRP) Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Harvest Technologies
    • 11.1.1 Harvest Technologies Corporation Information
    • 11.1.2 Harvest Technologies Overview
    • 11.1.3 Harvest Technologies Platelet Rich Plasma (PRP) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Harvest Technologies Platelet Rich Plasma (PRP) Product Description
    • 11.1.5 Harvest Technologies Related Developments
  • 11.2 DePuy Synthes
    • 11.2.1 DePuy Synthes Corporation Information
    • 11.2.2 DePuy Synthes Overview
    • 11.2.3 DePuy Synthes Platelet Rich Plasma (PRP) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 DePuy Synthes Platelet Rich Plasma (PRP) Product Description
    • 11.2.5 DePuy Synthes Related Developments
  • 11.3 Stryker
    • 11.3.1 Stryker Corporation Information
    • 11.3.2 Stryker Overview
    • 11.3.3 Stryker Platelet Rich Plasma (PRP) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Stryker Platelet Rich Plasma (PRP) Product Description
    • 11.3.5 Stryker Related Developments
  • 11.4 Zimmer Biomet
    • 11.4.1 Zimmer Biomet Corporation Information
    • 11.4.2 Zimmer Biomet Overview
    • 11.4.3 Zimmer Biomet Platelet Rich Plasma (PRP) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Zimmer Biomet Platelet Rich Plasma (PRP) Product Description
    • 11.4.5 Zimmer Biomet Related Developments
  • 11.5 Arthrex
    • 11.5.1 Arthrex Corporation Information
    • 11.5.2 Arthrex Overview
    • 11.5.3 Arthrex Platelet Rich Plasma (PRP) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Arthrex Platelet Rich Plasma (PRP) Product Description
    • 11.5.5 Arthrex Related Developments
  • 11.6 Exactech
    • 11.6.1 Exactech Corporation Information
    • 11.6.2 Exactech Overview
    • 11.6.3 Exactech Platelet Rich Plasma (PRP) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Exactech Platelet Rich Plasma (PRP) Product Description
    • 11.6.5 Exactech Related Developments
  • 11.7 Emcyte Corporation
    • 11.7.1 Emcyte Corporation Corporation Information
    • 11.7.2 Emcyte Corporation Overview
    • 11.7.3 Emcyte Corporation Platelet Rich Plasma (PRP) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Emcyte Corporation Platelet Rich Plasma (PRP) Product Description
    • 11.7.5 Emcyte Corporation Related Developments
  • 11.8 Arteriocyte
    • 11.8.1 Arteriocyte Corporation Information
    • 11.8.2 Arteriocyte Overview
    • 11.8.3 Arteriocyte Platelet Rich Plasma (PRP) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Arteriocyte Platelet Rich Plasma (PRP) Product Description
    • 11.8.5 Arteriocyte Related Developments
  • 11.9 Adilyfe
    • 11.9.1 Adilyfe Corporation Information
    • 11.9.2 Adilyfe Overview
    • 11.9.3 Adilyfe Platelet Rich Plasma (PRP) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Adilyfe Platelet Rich Plasma (PRP) Product Description
    • 11.9.5 Adilyfe Related Developments
  • 11.1 Harvest Technologies
    • 11.1.1 Harvest Technologies Corporation Information
    • 11.1.2 Harvest Technologies Overview
    • 11.1.3 Harvest Technologies Platelet Rich Plasma (PRP) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Harvest Technologies Platelet Rich Plasma (PRP) Product Description
    • 11.1.5 Harvest Technologies Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Platelet Rich Plasma (PRP) Value Chain Analysis
  • 12.2 Platelet Rich Plasma (PRP) Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Platelet Rich Plasma (PRP) Production Mode & Process
  • 12.4 Platelet Rich Plasma (PRP) Sales and Marketing
    • 12.4.1 Platelet Rich Plasma (PRP) Sales Channels
    • 12.4.2 Platelet Rich Plasma (PRP) Distributors
  • 12.5 Platelet Rich Plasma (PRP) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Platelet Rich Plasma (PRP) Industry Trends
  • 13.2 Platelet Rich Plasma (PRP) Market Drivers
  • 13.3 Platelet Rich Plasma (PRP) Market Challenges
  • 13.4 Platelet Rich Plasma (PRP) Market Restraints

14 Key Findings in The Global Platelet Rich Plasma (PRP) Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Platelet Rich Plasma (PRP) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Platelet Rich Plasma (PRP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    P-PRP
    L-PRP
    L-PRF

    Segment by Application
    Orthopedic Surgery
    Cosmetic Surgery
    General Surgery
    Other Surgeries

    By Company
    Harvest Technologies
    DePuy Synthes
    Stryker
    Zimmer Biomet
    Arthrex
    Exactech
    Emcyte Corporation
    Arteriocyte
    Adilyfe

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now